Details of the Drug
General Information of Drug (ID: DM4JQCR)
Drug Name |
(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL296435; (2S,3R)-EHNA; CHEBI:63059; (2S,3R)-3-(6-aminopurin-9-yl)nonan-2-ol; 79813-69-7; (S,R)-6-amino-beta-hexyl-alpha-methyl-9H-purine-9-ethanol; HWC 46; 2z7g; AC1L3ZQL; (+)-erythro-9-(2-Hydroxy-3-nonyl)adenine; SCHEMBL1742728; CTK2H9986; BDBM28393; IOSAAWHGJUZBOG-WDEREUQCSA-N; ZINC1558334; EH9; (S-(R*,S*))-6-Amino-beta-hexyl-alpha-methyl-9H-purine-9-ethanol; AKOS030531307; 9H-Purine-9-ethanol, 6-amino-beta-hexyl-alpha-methyl-, (S-(R*,S*))-; DB07711
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 277.37 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 7 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||